Member access

4-Traders Homepage  >  Shares  >  Deutsche Boerse AG  >  UCB SA    UNC   BE0003739530

UCB SA (UNC)

0
Real-time Quote. Real-time CHI-X EUROPE LIMITED. - 12/18 06:01:25 pm
65.1750 EUR   +2.64%
2d agoDJUCB : Advent, Avista End Acquisition Agreement
11/13 UCB : Transparency notification of Vanguard Health Care Fund
11/12 UCB : Transparency notification of Vanguard Health Care Fund
 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Deutsche Boerse Ag
12/12/2014 12/15/2014 12/16/2014 12/17/2014 12/18/2014 Date
65.48(c) 64.753(c) 63.442(c) 63.501(c) 64.96(c) Last
0 0 0 0 105 Volume
-0.56% -1.11% -2.02% +0.09% +2.30% Change
More quotes
Company
UCB SA is a biopharmaceutical company that engages in the research, development and commercialization of innovative drugs in the fields of central nervous system and immunology disorders.It focuses on the discovery and development of innovative medicines and solutions to transform the lives of... 
Sector
Pharmaceuticals
Calendar
02/25Earnings Release
More about the company
Surperformance© ratings of UCB SA
Trading Rating : Investor Rating :
More Ratings
Chart UCB SA
Duration : Period :
UCB SA Technical Analysis Chart | UNC | BE0003739530 | 4-Traders
Full-screen chart
Financials (€)
Sales 2014 3 446 M
EBIT 2014 481 M
Net income 2014 247 M
Debt 2014 1 255 M
Yield 2014 1,68%
Sales 2015 3 739 M
EBIT 2015 628 M
Net income 2015 359 M
Debt 2015 1 069 M
Yield 2015 1,89%
PER 2014 46,42
PER 2015 31,49
EV / Sales 2014 3,94x
EV / Sales 2015 3,58x
Capitalization 12 332 M
More Financials
Latest news on UCB SA
19h ago UCB : "Method for Producing Protein" in Patent Application Approval Process
2d agoDJUCB : Advent, Avista End Acquisition Agreement
12/05 UCB : Taps Cegedim Relationship Management Mobile Intelligence Cloud Platform
11/13 UCB : Transparency notification of Vanguard Health Care Fund
11/12 UCB : Transparency notification of Vanguard Health Care Fund
11/07 Belgium's UCB to sell generics unit for 964 million pounds
10/22 EXCLUSIVE- ADVENT, AVISTA NEAR DEAL : sources
10/21UCB SA : quaterly earnings release
More news
Sector news
7h ago Roche to pay up to $489 million for next-generation antibody developer
8h ago MERCK : buys Swiss biotech with promising cancer drug
10h ago France fines household product firms 951 million euros for price fixing
More sector news
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF